Form 8-K - Current report:
SEC Accession No. 0001193125-20-314122
Filing Date
2020-12-10
Accepted
2020-12-09 21:11:01
Documents
14
Period of Report
2020-12-07
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d22148d8k.htm   iXBRL 8-K 36509
2 EX-99.1 d22148dex991.htm EX-99.1 11378
6 GRAPHIC g22148g1210055816089.jpg GRAPHIC 3698
  Complete submission text file 0001193125-20-314122.txt   181166

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgc-20201207.xsd EX-101.SCH 3079
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgc-20201207_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgc-20201207_pre.xml EX-101.PRE 10960
7 EXTRACTED XBRL INSTANCE DOCUMENT d22148d8k_htm.xml XML 3323
Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38496 | Film No.: 201379243
SIC: 2833 Medicinal Chemicals & Botanical Products